PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-23.76%
Revenue decline while CRWD shows 5.94% growth. Joel Greenblatt would examine competitive position erosion.
-24.06%
Cost reduction while CRWD shows 7.31% growth. Joel Greenblatt would examine competitive advantage.
-23.68%
Gross profit decline while CRWD shows 5.45% growth. Joel Greenblatt would examine competitive position.
0.09%
Margin expansion while CRWD shows decline. John Neff would investigate competitive advantages.
6.78%
R&D growth above 1.5x CRWD's 3.75%. Michael Burry would check for spending discipline.
-2.62%
G&A reduction while CRWD shows 7.72% growth. Joel Greenblatt would examine efficiency advantage.
-11.49%
Marketing expense reduction while CRWD shows 1.68% growth. Joel Greenblatt would examine competitive risk.
-100.00%
Other expenses reduction while CRWD shows 0.00% growth. Joel Greenblatt would examine efficiency.
-4.45%
Operating expenses reduction while CRWD shows 3.48% growth. Joel Greenblatt would examine advantage.
-11.22%
Total costs reduction while CRWD shows 4.38% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
12.85%
D&A growth while CRWD reduces D&A. John Neff would investigate differences.
-36.32%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
-14.61%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-39.23%
Operating income decline while CRWD shows 9.37% growth. Joel Greenblatt would examine position.
-20.30%
Operating margin decline while CRWD shows 14.45% growth. Joel Greenblatt would examine position.
-54.59%
Other expenses reduction while CRWD shows 18.80% growth. Joel Greenblatt would examine advantage.
-39.87%
Pre-tax income decline while CRWD shows 20.26% growth. Joel Greenblatt would examine position.
-21.14%
Pre-tax margin decline while CRWD shows 24.73% growth. Joel Greenblatt would examine position.
-39.89%
Both companies reducing tax expense. Martin Whitman would check patterns.
-39.87%
Net income decline while CRWD shows 29.52% growth. Joel Greenblatt would examine position.
-21.13%
Net margin decline while CRWD shows 33.47% growth. Joel Greenblatt would examine position.
-38.67%
EPS decline while CRWD shows 29.55% growth. Joel Greenblatt would examine position.
-39.19%
Diluted EPS decline while CRWD shows 29.55% growth. Joel Greenblatt would examine position.
-1.00%
Share count reduction while CRWD shows 0.59% change. Joel Greenblatt would examine strategy.
-0.84%
Diluted share reduction while CRWD shows 0.59% change. Joel Greenblatt would examine strategy.